Venus Remedies Ltd. (VENUSREM)
Market Open
11 Aug, 10:00
XNSE XNSE Primary MSE ₹
1,477. 50
-45.1
-2.962%
₹
11.76B Market Cap
15.19 P/E Ratio
12% Div Yield
16,449 Volume
0 Eps
₹ 1,522.6
Previous Close Want to track VENUSREM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Venus Remedies Ltd. (VENUSREM) Statistics
Valuation metrics
Market Cap 11.76B
Enterprise value 20.41B
Trailing P/E (ttm) 17.73
Forward P/E -
PEG ratio 0.15
Price/Sales (ttm) 2.54
Price/Book (mrq) 3.1
Enterprise Value/Revenue 2.52
Enterprise Value/EBITDA 11.65
Overview
Shares outstanding 13.37M
Float 6.37M
Shares short -
% Held by insiders 0.48%
% Held by institutions 0.01%
Average volume (10 days) 27.96K
Average volume (90 days) 82.29K
Price summary
52-Week low 424
52-Week high 2,044.3
Beta 0.27
50-Day moving average 1,711.5
200-Day moving average 1,196.89
Dividends and splits
Forward annual dividend rate 12
Forward annual dividend yield 0.0139%
Trailing annual dividend rate 10
Trailing annual dividend yield 0.0065%
5-Year annual dividend yield 1.31%
Payout ratio -
Dividend Date 7 Aug 2026
Ex-Dividend Date 7 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.14%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.19%
Income Statement
Revenue (ttm) 7.03B
Revenue per share (ttm) 606.92
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 3.31B
EBITDA 1.26B
Net income to common (ttm) 762.85M
Diluted EPS (ttm) 86.91
Quarterly earnings growth (yoy) 0.3%
Balance Sheet
Total cash (mrq) 2.36B
Total cash per share (mrq) 78.11
Total debt (mrq) 143.8M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 2.44%
Book value per share (mrq) 496.55
Cash Flow
Cash flow statement 883.16M
Levered free cash flow (LFCF) 453.15M
